HIV Dementia
📧 Sign up to get email alerts when something new happens for HIV Dementia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Intranasal Insulin for the Treatment of HAND [Phase 1, Phase 2]
Phase 1/2 trial exploring intranasal insulin for HIV-associated neurocognitive disorders was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-23Clinical Trial Update: Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND) [Phase 4]
Phase 4 trial update on downmodulating monocyte activation for HIV-associated neurocognitive disorders has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: Modulation of Monocyte Activation by Atorvastatin in HIV Infection [Phase 4]
Phase 4 clinical trial assessing whether atorvastatin modulates monocyte activation in HIV infection with HIV dementia.
-
CLINICAL_TRIALS research · 2012-05-16Clinical Trial Update: A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV [Phase 3]
A Phase 3 clinical trial compares long-acting methylphenidate (Concerta) to placebo for memory loss associated with HIV dementia.